Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test brain chip to restore sight in the blind

NCT ID NCT04634383

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial is testing a brain implant designed to create artificial vision in people who are blind. Five participants will have a wireless device surgically placed in the part of the brain that processes vision. The study will check if the device is safe and whether it can produce visual perceptions through electrical stimulation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
wireless floating microelectrode array (brain implant)
What this could lead to
If successful, this could lead to a device that restores a form of artificial vision for people who are blind.
What could go wrong
This is a very early, small trial with only 5 people. The implant requires brain surgery, which carries risks like infection or bleeding. It may not produce useful vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2020

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * No light perception or bare light perception, in each eye in accordance with relevant International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes, where the physician has no expectation of improvement through currently approved treatments. * History of normal or near-normal vision, with or without refractive correction, during at least the first 10 years of life. * Adjusted to blindness for at least one year. * History of vision or blindness rehabilitation. * Willing and able to meet the time demands of the study with transportation assistance. * Willing to agree to audio and video recording, as specified in the pre-screening consent. * Motivated by altruism, willingness to participate in pioneering science. * Demonstrated support from spouse, family and/or friends. * High or average cognitive and spatial functioning. * Normal structural MRI. * English as preferred language. * Normal decision-making capacity. Exclusion Criteria: * Poor adjustment to blindness, or vision loss within the last year. * Expectation of vision restoration to pre-blindness level through trial participation. * History of alcohol or drug dependence. * Evidence of prior immune response to an orthopedic implant which caused the implant to be explanted * A disease prognosis of living less than five years. * An implant which would prevent screening using MRI, or a pacemaker, or similar implant. * A history of seizures. * Current suicidal ideation. * Poor decision-making capacity. * Current diagnosis or history of severe mental illness. * Women who are pregnant or plan on becoming pregnant in the duration of the trial. * Hand Motion (HM) vision or better vision, * No Light Perception (NLP) or Light Perception (LP) vision with present OptoKinetic Nystagmus (OKN) * NLP vision with pupil constriction * Patients with Islands of perceivable vision in Goldmann Visual Field or Confrontational visual Field will also be excluded from the study. * Patients with Complete media opacity (complete cornea opacity, very dense cataract) that does not allow visualization of the posterior segment to determine the cause of blindness will be excluded from the study. Only patients with NLP and LP vision without OKN will be included in the study. * Patients with NLP or LP vision since birth will also be excluded from the study, as they may not have fully developed higher visual pathways, including cortical connections

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blindness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Illinois Tech

    RECRUITING

    Chicago, Illinois, 60616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.